Regional kinetic constants and cerebral metabolic rate for glucose in normal human volunteers determined by dynamic positron emission tomography of [18F]-2-fluoro-2-deoxy-D-glucose
- PMID: 6609929
- DOI: 10.1038/jcbfm.1984.30
Regional kinetic constants and cerebral metabolic rate for glucose in normal human volunteers determined by dynamic positron emission tomography of [18F]-2-fluoro-2-deoxy-D-glucose
Abstract
Using dynamic [18F]fluorodeoxyglucose (FDG) positron emission tomography with a high-resolution, seven-slice positron camera, the kinetic constants of the original three-compartment model of Sokoloff and co-workers (1977) were determined in 43 distinct topographic brain regions of seven healthy male volunteers aged 28-38 years. Regional averages of the cerebral metabolic rate for glucose ( CMRglu ) were calculated both from individually fitted rate constants ( CMRglukinetic ) and from activity maps recorded 30-40 min after FDG injection, employing a four-parameter operational equation with standard rate constants from the literature ( CMRgluautoradiographic ). Metabolic rates and kinetic constants varied significantly among regions and subjects, but not between hemispheres. k1 ranged between 0.0485 +/- 0.00778 min-1 in the oval center and 0.0990 +/- 0.01347 min-1 in the primary visual cortex. k2 ranged from 0.1198 +/- 0.01533 min-1 in the temporal white matter to 0.1472 +/- 0.01817 min-1 in the cerebellar dentate nucleus. k3 was lowest (0.0386 +/- 0.01482 min-1) in temporal white matter and highest (0.0823 +/- 0.02552 min-1) in the caudate nucleus. Maximum likelihood cluster analysis revealed four homogeneous groups of brain regions according to their respective kinetic constants: (1) white matter and mixed brainstem structures; (2) cerebellar gray matter and hippocampal formations; (3) basal ganglia and frontolateral and primary visual cortex; and (4) other cerebral cortex and thalamus. Across the entire brain, k1 and k2 were positively correlated (r = 0.79); k1 and k3 showed some correlation (r = 0.59); but no significant linear association was found between k2 and k3. A strong correlation with CMRglu could be demonstrated for k1 (r = 0.88) and k3 (r = 0.90), but k2 was loosely correlated (r = 0.56). CMRglu kinetic ranged from 17.0 +/- 2.45 mumol/100 g/min in the occipital white matter to 41.1 +/- 5.62 mumol/100 g/min in the frontolateral cortex. In most regions the mean values of CMRglu kinetic did not differ significantly from CMRglu autoradiographic. With few exceptions, however, within-region variance was significantly less for CMRglu kinetic than for CMRglu autoradiographic, suggesting greater individual reliability of results obtained by the kinetic approach.
Similar articles
-
Diminished glucose transport and phosphorylation in Alzheimer's disease determined by dynamic FDG-PET.J Nucl Med. 1996 Feb;37(2):201-8. J Nucl Med. 1996. PMID: 8667045
-
Effect of vascular activity in the determination of rate constants for the uptake of 18F-labeled 2-fluoro-2-deoxy-D-glucose: error analysis and normal values in older subjects.J Cereb Blood Flow Metab. 1986 Dec;6(6):724-38. doi: 10.1038/jcbfm.1986.129. J Cereb Blood Flow Metab. 1986. PMID: 3491827
-
Determination of regional rate constants from dynamic FDG-PET studies in Parkinson's disease.J Nucl Med. 1996 Jul;37(7):1115-22. J Nucl Med. 1996. PMID: 8965180
-
Positron emission tomography imaging of regional cerebral glucose metabolism.Semin Nucl Med. 1986 Jan;16(1):2-34. doi: 10.1016/s0001-2998(86)80002-2. Semin Nucl Med. 1986. PMID: 2935938 Review.
-
Radiopharmaceuticals for positron emission tomography. Development of new, innovative tracers for measuring the rates of physiologic and biochemical processes.Acta Radiol Suppl. 1990;374:7-11. Acta Radiol Suppl. 1990. PMID: 1966972 Review.
Cited by
-
Comparative analysis of regional brain blood flow and glucose metabolism in focal cerebrovascular disease measured by dynamic positron emission tomography of fluorine-18-labelled tracers.J Neurol. 1987 Jun;234(5):315-21. doi: 10.1007/BF00314287. J Neurol. 1987. PMID: 3497233
-
Molecular imaging of brain tumors: a bridge between clinical and molecular medicine?Mol Imaging Biol. 2007 Mar-Apr;9(2):60-71. doi: 10.1007/s11307-006-0069-9. Mol Imaging Biol. 2007. PMID: 17203238 Review.
-
A new framework for metabolic connectivity mapping using bolus [18F]FDG PET and kinetic modeling.J Cereb Blood Flow Metab. 2023 Nov;43(11):1905-1918. doi: 10.1177/0271678X231184365. Epub 2023 Jun 28. J Cereb Blood Flow Metab. 2023. PMID: 37377103 Free PMC article.
-
Regional blood-brain barrier transport of glucose after portacaval anastomosis.Metab Brain Dis. 1986 Jun;1(2):119-28. doi: 10.1007/BF00999382. Metab Brain Dis. 1986. PMID: 3508237
-
13C MRS studies of neuroenergetics and neurotransmitter cycling in humans.NMR Biomed. 2011 Oct;24(8):943-57. doi: 10.1002/nbm.1772. Epub 2011 Aug 31. NMR Biomed. 2011. PMID: 21882281 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous